Suchergebnisse - "Drake, Charles G"

PubPharm (479)

71

Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer : Combination Therapy in the First-Line Setting

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Aggen, D. | Drake, C. | Rini, B.

72

Insights from immuno-oncology : the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

enthalten in: Journal for immunotherapy of cancer | 2020

von Ascierto, P. | Fox, B. | Urba, W. | +31

ErratumIn: J Immunother Cancer. 2020 Apr;8(1):. - PMID 32345630

73

Management of Patients with Advanced Prostate Cancer : Report of the Advanced Prostate Cancer Consensus Conference 2019

enthalten in: European urology | 2020

von Gillessen, S. | Attard, G. | Beer, T. | +69

CommentIn: Eur Urol. 2020 Nov;78(5):e201-e202. - PMID 32222292

74

Defining tumor resistance to PD-1 pathway blockade : recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce

enthalten in: Journal for immunotherapy of cancer | 2020

von Kluger, H. | Tawbi, H. | Ascierto, M. | +22

75

Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy

enthalten in: The Prostate | 2020

von Hawley, J. | Pan, S. | Figg, W. | +8

76

A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer

enthalten in: Prostate cancer and prostatic diseases | 2020

von Ross, A. | Hurley, P. | Tran, P. | +9

CommentIn: Prostate Cancer Prostatic Dis. 2020 Sep;23(3):537-538. - PMID 32076122

77

A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target

enthalten in: The Journal of clinical investigation | 2020

von Freeman, Z. | Nirschl, T. | Hovelson, D. | +17

78

Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens

enthalten in: Nature biotechnology | 2020

von Lynn, G. | Sedlik, C. | Baharom, F. | +27

79

Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer : Implications for Prospective BCG-Unresponsive Trials

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Kates, M. | Matoso, A. | Choi, W. | +17

CommentIn: Nat Rev Urol. 2020 Jan;17(1):8. - PMID 31792432

80

Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer : Multicohort, Open-Label Phase II KEYNOTE-199 Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Antonarakis, E. | Piulats, J. | Gross-Goupil, M. | +21

CommentIn: J Clin Oncol. 2020 Feb 10;38(5):381-383. - PMID 31877088